“amyotrophic-lateral-sclerosis-als” Archives

in
Entry Author Date Location
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma 10/10/19 Boston
Stealth Bio’s IPO Raises $78M for Clinical Tests of Mitochondrial Drugs 02/15/19 Boston
Alector Files for IPO to Fund Studies of Alzheimer’s, Dementia Drugs 01/07/19 San Francisco
Bio-JPM Roundup: Lilly Buys Loxo, Sage’s Stock Soars, ALS Cash & More 01/07/19 National
Sanofi Pledges $125M to Denali in Pact for Neuro, Inflammation Drugs 11/01/18 San Francisco
Bio Roundup: Duchenne Data, Roche Buys Foundation, IPO Wave & More 06/22/18 National
In Biggest Biotech IPO of 2017, Denali Raises $248M for Neuro Drugs 12/08/17 San Francisco
Bio Roundup: Migraine Data, Cancer Drug Combos, Azar Hearing & More 12/01/17 National
Cytokinetics Pivots to Another ALS Drug After Phase 3 Failure 11/21/17 San Francisco
Disarm Launches With $30M From Atlas, AbbVie to Battle Neuro Disease 09/19/17 Boston
Advancing Drugs at Roche, Sophiris, Coherus, and Other Bio News 11/13/15 San Diego
Avalon, GSK Extend Collaboration with Startup Focused on ALS 11/09/15 San Diego
Page 1 of 1